Jonathan Novak

Jonathan Novak is an experienced professional in DMPK with a current position as Senior Director of DMPK at Pretzel Therapeutics since November 2023. Previously served as Director of DMPK at Ribon Therapeutics, leading the DMPK group for inflammation and oncology programs. Held the role of Associate Director of DMPK and Principal Scientist at Praxis Precision Medicines, focusing on CNS diseases and leading the PRAX-628 focal epilepsy program. Prior experience includes roles as Senior Scientist and Scientist at Pfizer, contributing to preclinical and first-in-human projects across various research units. Began a career as a Research Associate - Biochemist at the University of Connecticut. Academic qualifications include a Master of Science in Bioinformatics from The Johns Hopkins University and a Bachelor of Science in Molecular and Cell Biology from the University of Connecticut.